Riken Vitamin Co., Ltd.【JP:4526】Cash flow
Market cap
¥91.8B
P/E ratio
10.8x
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 3,902 | 3,388 | 3,496 | 3,639 | 3,915 | 4,072 | 3,955 | 3,736 | 3,718 | 3,330 | 3,204 |
| Cash from operations | 5,941 | 8,377 | 8,126 | 5,753 | 6,689 | 5,850 | 7,625 | 6,823 | 7,835 | 10,451 | 7,892 |
| Capital expenditures | -5,487 | -5,971 | -2,810 | -2,997 | -3,917 | -5,275 | -3,697 | -3,250 | -2,112 | -2,536 | -4,678 |
| Cash from investing | -5,690 | -6,389 | -3,080 | -1,617 | -3,388 | -4,282 | -2,288 | -3,661 | -2,034 | -554 | 353 |
| Payments for dividends | -1,270 | -1,399 | -1,277 | -1,066 | -1,251 | -1,376 | -1,410 | -1,385 | -1,582 | -2,194 | -2,776 |
| Repurchases of common stock | - | -472 | -24,420 | -299 | -173 | -1 | - | - | - | -6,360 | -1,133 |
| Proceeds from issuance of term debt, net | - | - | 22,000 | - | 270 | 687 | - | 18,237 | - | - | 5,000 |
| Repayments of term debt | -356 | -274 | -1,196 | -2,203 | -2,206 | -2,027 | -2,057 | -14,289 | -2,606 | -2,606 | -7,138 |
| Cash from financing | -1,222 | -3,140 | -1,881 | -5,869 | -2,490 | -3,051 | -180 | -7,565 | -4,578 | -7,084 | -9,965 |